MicroRNA antagonism of the picornaviral life cycle: Alternative mechanisms of interference

PLoS Pathogens

Volumn 6, Issue 3, 2010, Pages

  Kelly, Elizabeth J ^a   Hadac, Elizabeth M ^a   Cullen, Bryan R ^b   Russell, Stephen J ^a  

^a Mayo Clinic   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; CANCER VACCINE; MIRN142 MICRORNA, MOUSE; VIRUS RNA;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER MODEL; CATALYSIS; CONTROLLED STUDY; COXSACKIE VIRUS A; HUMAN; HUMAN CELL; LIFE CYCLE; MOUSE; NONHUMAN; RNA DEGRADATION; RNA TRANSLATION; VIRUS CAPSID; VIRUS INTERFERENCE; VIRUS REPLICATION; ANIMAL; CANCER TRANSPLANTATION; CHRONIC LYMPHATIC LEUKEMIA; COXSACKIE VIRUS INFECTION; DISEASE MODEL; ENTEROVIRUS; GENETICS; GROWTH, DEVELOPMENT AND AGING; HELA CELL; MELANOMA; MOLECULAR GENETICS; MOUSE MUTANT; MUTAGENESIS; NUCLEOTIDE SEQUENCE; PROTEIN SYNTHESIS; RNA INTERFERENCE; VIROLOGY; XENOGRAFT;

COXSACKIEVIRUS; PICORNAVIRIDAE;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; CANCER VACCINES; COXSACKIEVIRUS INFECTIONS; DISEASE MODELS, ANIMAL; ENTEROVIRUS; HELA CELLS; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MELANOMA; MICE; MICE, SCID; MICRORNAS; MOLECULAR SEQUENCE DATA; MUTAGENESIS; NEOPLASM TRANSPLANTATION; PROTEIN BIOSYNTHESIS; RNA INTERFERENCE; RNA, VIRAL; TRANSPLANTATION, HETEROLOGOUS;

EID: 77950446517     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000820     Document Type: Article

References (32)

1. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
2. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36: D154-158.
3. Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, et al. (2008) The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 10: 202-210.
4. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
5. Brown BD, Gentner B, Cantore A, Colleoni S, Amendola M, et al. (2007) Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat Biotechnol.
6. Westerhout EM, Ooms M, Vink M, Das AT, Berkhout B (2005) HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res 33: 796-804. (Pubitemid 40361009)
7. Gu S, Jin L, Zhang F, Sarnow P, Kay MA (2009) Biological basis for restriction of microRNA targets to the 3′ untranslated region in mammalian mRNAs. Nat Struct Mol Biol 16: 144-150.
8. Pillai RS, Bhattacharyya SN, Artus CG, Zoller T, Cougot N, et al. (2005) Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science 309: 1573-1576. (Pubitemid 41266485)
9. Humphreys DT, Westman BJ, Martin DI, Preiss T (2005) MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc Natl Acad Sci U S A 102: 16961-16966.
10. Barnes D, Kunitomi M, Vignuzzi M, Saksela K, Andino R (2008) Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines. Cell Host Microbe 4: 239-248.
11. Cawood R, Chen HH, Carroll F, Bazan-Peregrino M, van Rooijen N, et al. (2009) Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells. PLoS Pathog 5: e1000440. doi:10.1371/journal.ppat.1000440.
12. Ylosmaki E, Hakkarainen T, Hemminki A, Visakorpi T, Andino R, et al. (2008) Generation of a conditionally replicating adenovirus based on targeted destruction of E1A mRNA by a cell type-specific microRNA. J Virol 82: 11009-11015.
13. Kelly EJ, Hadac EM, Greiner S, Russell SJ (2008) Engineering microRNA responsiveness to decrease virus pathogenicity. Nat Med 14: 1278-1283.
14. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P (2005) Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309: 1577-1581. (Pubitemid 41266486)
15. Brown BD, Venneri MA, Zingale A, Sergi Sergi L, Naldini L (2006) Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer. Nat Med 12: 585-591.
16. Gottwein E, Cullen BR (2008) Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe 3: 375-387.
17. Sullivan CS, Grundhoff AT, Tevethia S, Pipas JM, Ganem D (2005) SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 435: 682-686. (Pubitemid 40825513)
18. Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, et al. (2007) Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449: 919-922. (Pubitemid 47598616)
19. Kelly EJ, Russell SJ (2009) MicroRNAs and the regulation of vector tropism. Mol Ther 17: 409-416.
20. Schiff GM, Sherwood JR (2000) Clinical activity of pleconaril in an experimentally induced coxsackievirus A21 respiratory infection. J Infect Dis 181: 20-26.
21. Dekel B, Yoeli R, Shulman L, Padeh S, Passwell JH (2002) Localized thigh swelling mimicking a neoplastic process: involvement of coxsackie virus type A21. Acta Paediatr 91: 357-359. (Pubitemid 34270879)
22. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008) Mechanisms of posttranscriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 102-114.
23. Petersen CP, Bordeleau ME, Pelletier J, Sharp PA (2006) Short RNAs repress translation after initiation in mammalian cells. Mol Cell 21: 533-542. (Pubitemid 43228008)
24. Mathonnet G, Fabian MR, Svitkin YV, Parsyan A, Huck L, et al. (2007) MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science 317: 1764-1767. (Pubitemid 47461843)
25. Gentner B, Schira G, Giustacchini A, Amendola M, Brown BD, et al. (2009) Stable knockdown of microRNA in vivo by lentiviral vectors. Nat Methods 6: 63-66.
26. Teterina NL, Zhou WD, Cho MW, Ehrenfeld E (1995) Inefficient complementation activity of poliovirus 2C and 3D proteins for rescue of lethal mutations. J Virol 69: 4245-4254.
27. Van Der Velden A, Kaminski A, Jackson RJ, Belsham GJ (1995) Defective point mutants of the encephalomyocarditis virus internal ribosome entry site can be complemented in trans. Virology 214: 82-90.
28. Jia XY, Van Eden M, Busch MG, Ehrenfeld E, Summers DF (1998) transencapsidation of a poliovirus replicon by different picornavirus capsid proteins. J Virol 72: 7972-7977. (Pubitemid 28421789)
29. Etchison D, Milburn SC, Edery I, Sonenberg N, Hershey JW (1982) Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex. J Biol Chem 257: 14806-14810.
30. Rose JK, Trachsel H, Leong K, Baltimore D (1978) Inhibition of translation by poliovirus: inactivation of a specific initiation factor. Proc Natl Acad Sci U S A 75: 2732-2736.
31. Wien MW, Chow M, Hogle JM (1996) Poliovirus: new insights from an old paradigm. Structure 4: 763-767. (Pubitemid 26312359)
32. Ebert MS, Neilson JR, Sharp PA (2007) MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat Methods 4: 721-726. (Pubitemid 47338166)